DARZALEX|pi.pdf
See full prescribing information for DARZALEX. DARZALEX® (daratumumab) injection, for intravenous use. Initial U.S. Approval: 2015. --------- ...
DARZALEX (daratumumab) - accessdata.fda.gov
The DARZALEX dosing schedule in Table 3 is for combination therapy with bortezomib and dexamethasone (3-week cycle regimen) for patients with relapsed/ ...
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj ...
See full prescribing information for DARZALEX FASPRO. DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) injection, for subcutaneous use. Initial U.S. ...
Reference ID: 4947469 - accessdata.fda.gov
See full prescribing information for. DARZALEX. DARZALEX® (daratumumab) injection, for intravenous use. Initial U.S. Approval: 2015. --------- ...
darzalex-epar-product-information_en.pdf
DARZALEX is indicated: • in combination with lenalidomide and dexamethasone or with bortezomib, melphalan and prednisone for the treatment of adult patients ...
Dosing and Administration Guide - darzalex faspro
INDICATIONS. DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) is indicated for the treatment of adult patients with multiple myeloma:.
darzalex-faspro-patient-brochure.pdf
What is DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)?. DARZALEX FASPRO® is a prescription medicine used to treat adult patients with multiple.
Dosing and Administration Guide - Darzalex
INDICATIONS. DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) is indicated for the treatment of adult patients with multiple myeloma:.
1. HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use. FORTEO safely and effectively.
AJOVY® (fremanezumab-vfrm) injection. FRE-44455. HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use ...
ofev-us-pi.pdf - Boehringer Ingelheim
See full prescribing information for OFEV. OFEV® (nintedanib capsules), for oral use. Initial U.S. Approval: 2014. --------- ...
BAVENCIO® (avelumab) Prescribing Information - EMD Serono
HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use. BAVENCIO safely and effectively. See full prescribing ...
DARZALEX is indicated: • as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, whose prior therapy included a ...
See full prescribing information for KEYTRUDA. KEYTRUDA® (pembrolizumab) injection, for intravenous use. Initial U.S. Approval: 2014. --------- ...
See full prescribing information for TECARTUS. TECARTUS® (brexucabtagene autoleucel) suspension for intravenous infusion. Initial U.S. Approval: 2020. ------- ...
DARZALEX® (daratumumab) is indicated: • in combination with lenalidomide and dexamethasone, or with bortezomib, melphalan and prednisone, for ...
FULL PRESCRIBING INFORMATION. 1 INDICATIONS AND USAGE. 1.1 Infantile Spasms. Acthar Gel is indicated as monotherapy for the treatment of infantile spasms in ...
RITUXAN® (rituximab) injection, for intravenous use - Genentech
See 17 for PATIENT COUNSELING INFORMATION and Medication. Guide. Revised: 12/2021. Page 3. FULL PRESCRIBING INFORMATION: CONTENTS*. WARNING: ...
Prior to COSENTYX initiation, complete all age-appropriate vaccinations, evaluate patients for tuberculosis (TB). (2.1). See Full Prescribing. Information for ...
OPDIVO U.S. Prescribing Information - Bristol Myers Squibb
T4N2) NSCLC (per the AJCC Cancer Staging Manual 8th Edition) [see Clinical Studies. (14.4)]. Patients with active autoimmune disease or a medical condition ...